Jennifer H. Martin

Last updated

Jennifer Helen Martin FAHMS FRACP is an Australian clinical pharmacologist, physician and academic. She is chair of Clinical Pharmacology in the University of Newcastle School of Medicine and Public Health, [1] Director of the NHMRC funded Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE), [1] and a Fellow of the Australian Academy of Health and Medical Sciences. [2] Martin is also Editor-in-Chief of the academic journal Pharmacology Research & Perspectives. [3] Martin translates research into practice and policy. Her research involves the investigation of therapeutic drugs, from drug design and development, to clinical trials and studies to investigate how new drugs perform in the general population.

Contents

Governance roles include President-Elect of the RACP and President from May 2024; Council Member of the University of Newcastle and the NSW Council AICD

Early life

Martin grew up in Wellington, New Zealand where she followed an early interest in medicine from her love of sport, hoping to one day be the doctor who travelled with the New Zealand Olympic team. [1]

After studying medicine at the University of Otago, moved to work and study in the United Kingdom in 1993, later returning to New Zealand to train as a specialist in pharmacology and internal medicine. Martin moved to Melbourne to undertake a PhD in Medicine in 2000.

Career

Martin is a Rhodes Scholar who studied PPE and health economics at the University of Oxford. She completed a Bachelor of Medicine and Surgery from the University of Otago [1] and a Doctor of Philosophy at Monash University in 2005, examining innate immunity and heart failure pathophysiology in people with type 2 diabetes. [4] Her post-doctoral work investigated macrophage function in high fat diet at the Walter and Eliza Hall Institute.

Following her post-doctoral studies, Martin became the Head of Southside Clinical School at the University of Queensland where she was involved in revising the medical curricula to broaden medical student experiences in healthcare. Martin took on the leadership position of Chair of Clinical Pharmacology at the University of Newcastle in 2013. [1]

Martin was elected a Fellow of the Australian Academy of Health and Medical Sciences in 2020. [2] In the same year she published a report of clinical trials in Australia of using increasingly legal medicines based on cannabis. The report gave advice on ethics and keeping patients safe. [5]

Martin resigned as staff-elected Councillor from the University of Newcastle Council in June 2021 in protest at the appointment of Whitehaven Coal Chairman Mark Vaile as Chancellor. Vaile did not take up the Chancellor role and Martin was re-elected to the University Council in October 2021 [6]

Related Research Articles

Medical psychology or medico-psychology is the application of psychological principles to the practice of medicine, sometimes using drugs for both physical and mental disorders.

<span class="mw-page-title-main">Podiatry</span> Medicine branch focusing on the human lower extremities

Podiatry, or podiatric medicine and surgery, is a branch of medicine devoted to the study, diagnosis, and treatment of disorders of the foot, ankle and lower limb. The healthcare professional is known as a podiatrist. The US podiatric medical school curriculum includes lower extremity anatomy, general human anatomy, physiology, general medicine, physical assessment, biochemistry, neurobiology, pathophysiology, genetics and embryology, microbiology, histology, pharmacology, women's health, physical rehabilitation, sports medicine, research, ethics and jurisprudence, biomechanics, general principles of orthopedic surgery, plastic surgery, and foot and ankle surgery.

<span class="mw-page-title-main">Council for International Organizations of Medical Sciences</span> International non-governmental medical science organization

The Council for International Organizations of Medical Sciences (CIOMS) is an international non-governmental organization of 40 international, national, and associate member groups representing the biomedical science community. It was jointly established by the World Health Organization (WHO) and United Nations Educational, Scientific and Cultural Organization (UNESCO) in 1949 as a successor to the International Medical Congress that organized 17 conferences from 1867 until the 1913 outbreak of World War I.

Richard Graeme Larkins is the former Chancellor of La Trobe University. He was the Vice-Chancellor and President of Monash University from 2003 to June 2009. Prior to this, he had a distinguished career in medicine, scientific research and academic management.

The Monash University Faculty of Medicine, Nursing and Health Sciences is an Australian healthcare provider. It comprises 10 schools, teaching and clinical centers and research institutes. The faculty offers undergraduate, postgraduate and professional education programs in medicine, nursing and allied health, and is a member of the M8 Alliance of Academic Health Centers, Universities and National Academies.

An ethics committee is a body responsible for ensuring that medical experimentation and human subject research are carried out in an ethical manner in accordance with national and international law.

Professor Murray David Esler, is a clinical cardiologist and medical scientist, based at the Baker Heart and Diabetes Institute and the Alfred Hospital in Melbourne, where he is the Associate Director of the Heart Centre. He is a Professor of Medicine at Melbourne's Monash University. As Associate Director of the Baker, Professor Esler leads the Institute’s research into the relationship between the brain and heart health. He studied medicine at the University of Melbourne and received a PhD from the Australian National University. His chief research interests are the causes and treatment of high blood pressure and heart failure, the effects of stress on the cardiovascular system, and monoamine transmitters of the human brain.

The following outline is provided as an overview of and topical guide to clinical research:

The Baker Heart and Diabetes Institute, commonly known as the Baker Institute, is an Australian independent medical research institute headquartered in Melbourne, Victoria. Established in 1926, the institute is one of Australia's oldest medical research organisations with a historical focus on cardiovascular disease. In 2008, it became the country's first medical research institute to target diabetes, heart disease, obesity and their complications at the basic, clinical and population health levels.

<span class="mw-page-title-main">Harbin Medical University</span> Public university in Heilongjiang, China

Harbin Medical University (HMU) (Chinese: 哈尔滨医科大学) is a public university located in Harbin, Heilongjiang, China.

Michael Cowley FTSE is an Australian physiologist. He is best known for his mapping of the neural circuits involved in metabolism and obesity and diabetes treatment. He is a professor in the Department of Physiology at Monash University in the Faculty of Biomedical and Psychological Sciences. He is also a director of the Australian diabetes drug development company, Verva Inc, and director of the Monash Obesity & Diabetes Institute] (modi).

David Ofori-Adjei is a Ghanaian physician, medical researcher, academic and medical journal editor. His main areas of research are clinical pharmacology, pharmacogenetics, infectious diseases such as malaria, schistosomiasis, Buruli ulcer, and HIV/AIDS and public sector pharmaceutical management. He is currently the Editor-in-Chief of the Ghana Medical Journal.

Nicholas "Nick" Talley FRACP, FAFPHM, FRCP (Lond), FRCP (Edin), FACP, FACG, AGAF, FAHMS is an Australian gastroenterologist, epidemiologist, researcher, and clinical educator. Most of his work centers on FGIDs.

Stephen William MacMahon AO DSc FAA FMediSci FAHMS FACC is a British-Australian academic medical researcher, healthcare entrepreneur and founder of The George Institute for Global Health. He holds professorial academic appointments in medicine at UNSW Sydney and Imperial College London.

<span class="mw-page-title-main">Ranjit Roy Chaudhury</span>

Ranjit Roy Chaudhury, was an Indian clinical pharmacologist, medical academic and health planner, who headed the National Committee for formulating the policy and guidelines on drugs and clinical trials in India. He was the chairman of the joint programme of World Health Organization and Government of India on Rational Use of Drugs in India. He was the founder president of the Delhi Medical Council and the president of the Delhi Society for Promotion of Rational Use of Drugs.

<span class="mw-page-title-main">Medical cannabis research</span> Medical research on using cannabis

Medical cannabis research includes any medical research on using cannabis. The earliest systematic studies of physiological effects of cannabis-derived chemical were conducted in the 1920's. The level or research activity in this area remained relatively low and constant until 1966, when a 10-fold increase in publication activity occurred within 10 years. After the adoption of the Convention on Psychotropic Substances in 1971 there was a drop in research publishing, which continued till ca. 1987. Since then, cannabis research has been continuously on the rise. There is no apparent inflection point is 2013, when Uruguay "became the first country in the world to fully regulate its marijuana market, from production to consumption and distribution." Since then a large number of countries enacted policies on medical cannabis research, and there are substantial differences between such policies in different countries.

The Cannabinoid Research Initiative of Saskatchewan (CRIS) was founded in 2017 as an interdisciplinary research team of clinician researchers (medical and veterinary), basic scientists, and social scientists. CRIS aims to obtain scientific evidence about the application of Cannabinoids and Medical cannabis to humans and animals, for health, disease and disorders. The team was initially based at the University of Saskatchewan, in Saskatoon, Saskatchewan, Canada but includes researchers based at the University of Regina and University of Alberta. A strategic management executive committee coordinates activities and develops research opportunities. The sections of CRIS include: Analytical Evaluations, Human Clinical Studies, Biomedical studies, Veterinary Sciences, Knowledge Translation and Studies of Cannabinoids and Society. CRIS members participate in the Canadian Consortium for the Investigation of Cannabinoids, and the International Cannabinoid Research Society.

<span class="mw-page-title-main">Rachelle Buchbinder</span> Australian rheumatologist and medical researcher

Rachelle Buchbinder is an Australian rheumatologist and clinical epidemiologist. Her clinical practice is in conjunction with research involving multidisciplinary projects relating to arthritis and musculoskeletal conditions. She promotes improvement of communication with patients and health literacy in the community.

Dr Jean Gray is a Canadian academic and retired physician, who is professor emeritus of medical education, medicine and pharmacology at Dalhousie University. She has served as president of the Canadian and American Society of Clinical Pharmacology. She was invested as a Member of the Order of Canada in 2005, and has been a Fellow of the Royal College of Physicians since 2007. She was inducted into the Canadian Medical Hall of Fame in 2020.

References

  1. 1 2 3 4 5 "Staff Profile". www.newcastle.edu.au. 16 January 2015. Retrieved 12 October 2021.
  2. 1 2 "Academy elects 28 new Fellows". AAHMS - Australian Academy of Health and Medical Sciences. 14 October 2020. Retrieved 12 October 2021.
  3. ↑ "Pharmacology Research & Perspectives".
  4. ↑ "The pathophysiology of heart failure in type 2 diabetes". monash.hosted.exlibrisgroup.com. Retrieved 12 October 2021.
  5. ↑ Martin, Jennifer H.; Hill, Courtney; Walsh, Anna; Efron, Daryl; Taylor, Kaitlyn; Kennedy, Michael; Galettis, Rachel; Lightfoot, Paul; Hanson, Julie; Irving, Helen; Agar, Meera (17 November 2020). "Clinical trials with cannabis medicines—guidance for ethics committees, governance officers and researchers to streamline ethics applications and ensuring patient safety: considerations from the Australian experience". Trials. 21 (1): 932. doi: 10.1186/s13063-020-04862-6 . ISSN   1745-6215. PMC   7673085 . PMID   33203469.
  6. ↑ Hare, Julie (19 October 2021). "Vaile's nemesis reappointed to Newcastle University". The Australian Financial Review.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.